Unspecified THC/CBD formulation (deltas-9-tetrahydrocannabinol and cannabidiol)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Unspecified THC/CBD formulation (deltas-9-tetrahydrocannabinol and cannabidiol), covering 2012-09-19 to 2012-09-19. Get the full timeline:
Most recent: Clinical Trial Update: An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients [Phase 3]